Five steps to successfully implement and evaluate propensity score matching in clinical research studies
To offer insight into the latest trends about these medications, Truveta Research has created the GLP-1 RA monitoring report, which will be updated periodically with fresh, timely data
once stable, recheck every 6-12 months Hypoglycemia risk : While tirzepatide's glucose-lowering effect is glucose-dependent, patients with type 2 diabetes taking concurrent sulfonylureas or insulin require dose adjustments of these medications to prevent hypoglycemia Pancreatitis : Acute pancreatitis has been reported with GLP-1 receptor agonists
Furthermore, lymphovascular invasion is a critical step in tumor dissemination and a strong adverse prognostic factor for breast cancer survival [26]
Dai Y, Guo J, Zhang B, Chen J, Ou H, He R-R, et al